Bioveris Corp Watch

from 8-K ~5 pages Non-Disclosure and Non-Solicitation Agreement

from 8-K ~5 pages Bioveris Corporation Severance Plan

from 8-K 1 page Amendment to the Bioveris Corporation Termination Protection Program

from 10-Q 5 pages Ecl Settlement Agreement

from 10-Q 31 pages Lease Agreement

from 10-Q 29 pages Lease Agreement

from 10-Q 1 page Bioveris Corporation Charter of the Governance and Nominating Committee of the Board of Directors

from 10-K 16 pages Agreement

from 10-K 11 pages The Purpose of This Letter Agreement (“Agreement”) Is to Identify the Services That Have Been Provided by Igen International, Inc., a Delaware Corporation (“Igen”)located at 16020 Industrial Drive, Gaithersburg, MD 20877 to Each of Wellstat Therapeutics Corporation, Wellstat Biologics Corporation, Hyperion Catalysis International Corporation, Proteinix, Inc. and Integrated Chemical Synthesis, Inc. (Collectively the “Recipients”). This Agreement Will Also Memorialize the Terms and Conditions Under Which Those Services Have Been Provided by Igen to the Recipients. 1. Services

from S-4/A ~5 pages Equity Rights Purchase and License Agreement

from S-4/A ~10 pages Equity Rights Purchase and License Agreement

from S-4/A 1 page Letter Agreement

from S-4/A 1 page Letter Agreement

from S-4/A ~20 pages Solicitation, Offer and Award

from S-4/A ~20 pages Solicitation, Offer and Award Dated July 20, 2003

from S-4/A ~5 pages Termination Protection Program

from S-4/A ~5 pages Form of Indemnity Agreement